Greenyn Biotechnology Co

Greenyn Biotechnology Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Greenyn Biotechnology Co (6846.TWO) as of Nov 20, 2026 is 188.81 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 167.86 M TWD — a change of 12.48% (higher).

EBITDA

188.81 MTWD

YoY

12.48%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Greenyn Biotechnology Co is 2025 188.81 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Greenyn Biotechnology Co was 2024 167.86 M TWD. It decreases by 12.48% higher compared to the previous year.

The Greenyn Biotechnology Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
129.70 M TWD
Jan 1, 2020
159.65 M TWD
Jan 1, 2021
169.13 M TWD
Jan 1, 2022
184.04 M TWD
Jan 1, 2023
160.85 M TWD
Jan 1, 2024
167.86 M TWD
Jan 1, 2025
188.81 M TWD
The Greenyn Biotechnology Co EBITDA history
YEAREBITDAYoY
188.81 MTWD+12.48%
167.86 MTWD+4.36%
160.85 MTWD-12.60%
184.04 MTWD+8.82%
169.13 MTWD+5.94%
159.65 MTWD+23.09%
129.70 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Greenyn Biotechnology Co Stock analysis

What does Greenyn Biotechnology Co do? Greenyn Biotechnology Co., Ltd. generates revenue through the research, development, manufacture, and sales of health food raw materials across three business segments: health ingredients, health formulations, and other segments. Its main products include Antrodia cinnamomea mycelia, Bitter melon extract (Insumate), and 101 Phyto Fermented Drink, which are primarily sold in Taiwan and other Asian regions. The company focuses on supplying these health-focused products to customers within the Asian market, leveraging its product portfolio for regional demand. The firm's product lineup targets health-conscious consumers seeking natural health solutions, with Antrodia cinnamomea mycelia and Bitter melon extract (Insumate) serving as key offerings. 101 Phyto Fermented Drink represents another core product, emphasizing plant-based health benefits. These products are distributed through established channels in Taiwan and neighboring Asian markets, supporting the company's regional sales strategy. Greenyn Biotechnology's business model centers on developing and commercializing specialized health ingredients and formulations, with a strong emphasis on Asian market penetration. The company's revenue streams are derived from the direct sale of its proprietary health food raw materials to customers in Taiwan and other Asian regions, without mentioning external partners or additional distribution channels beyond the specified markets. Greenyn Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Greenyn Biotechnology Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Greenyn Biotechnology Co is 188.81 M TWD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Greenyn Biotechnology Co changed from 167.86 M TWD to 188.81 M TWD, representing a 12.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Greenyn Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Greenyn Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Greenyn Biotechnology Co

All Key Metrics — Greenyn Biotechnology Co